ANG and diabetic kidney disease: Thus, our study suggests that pharmacological inhibition of the β-adrenoceptor/renin/Ang pathway is beneficial to prevent the development of DPN, in addition to diabetic nephropathy and cardiomyopathy3,31,32, in T2DM patients.